The present invention relates to compounds of the following formula (I): and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.本發明有關具下式(I)之化合物:和/或其藥學上可接受之加成鹽、溶劑化物、鏡像異構物、非鏡像異構物以及混合物。本發明之標的因此亦包括式(I)化合物之製備、其等之用途,特別是在抑制與例如許多疾病(諸如癌症或免疫系統病症)有關聯之蛋白質激酶方面。